Genotype-guided fluoropyrimidine dosing: ready for implementation

Lancet Oncol. 2018 Nov;19(11):1421-1422. doi: 10.1016/S1470-2045(18)30744-7. Epub 2018 Oct 19.

Authors

Ursula Amstutz¹, Carlo R Largiadèr²

Affiliations

¹ University Institute of Clinical Chemistry, Inselspital Bern University Hospital, University of Bern, Bern 3010, Switzerland. Electronic address: ursula.amstutz@insel.ch.
² University Institute of Clinical Chemistry, Inselspital Bern University Hospital, University of Bern, Bern 3010, Switzerland.

PMID: 30348539
DOI: 10.1016/S1470-2045(18)30744-7

No abstract available

Publication types

Comment

MeSH terms

Anticoagulants*
Genotype
Humans
Neoplasms*
Prospective Studies

Substances

Anticoagulants